Understanding the Value of Community Vital Signs in Primary Care
NCT ID: NCT02512835
Last Updated: 2018-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2015-10-31
2016-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Risk Factors and Discrimination in Cancer Survivorship
NCT05301114
Implementing Personal Health Records to Promote Evidence-Based Cancer Screening
NCT02138448
A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2
NCT02973022
Learning and Relationships in Primary Care
NCT00657696
Implementation of Evidence-Based Cancer Early Detection in Black Churches
NCT02076958
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 1a: Determine community vital sign cold spots in the catchment area of 12 primary care practices.
Aim 1b: Determine whether patients residing in cold spots experience worse outcomes, such as receiving inadequate care, worse chronic disease control, or higher morbidity.
Aim 2: Determine whether knowing a patient's community vital signs and social needs at the point of care will change clinical management; and explore how practices could use community vital signs for population care.
Aim 3: Identify other community vital signs that practices would find useful for managing patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinic patients
Aims 1a and 1b: The participants include all unique patients seen at the 12 study practices (approximately 170,000 patients over the past two years).
No interventions assigned to this group
Clinicians
Aims 2 and 3: The clinicians in this analysis will include 15 participants recruited from the approximately 100 clinicians at the 12 practices
Community vital signs
We will present clinicians with information about their patients' communities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Community vital signs
We will present clinicians with information about their patients' communities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aims 2 and 3: Clinicians at one of the 12 study practices
Exclusion Criteria
* Aims 2 and 3: Clinicians involved with the design of the research protocol.
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alex Krist, M.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fairfax Family Practice Centers
Fairfax, Virginia, United States
Virginia Ambulatory Care Outcomes Research Network
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM20004050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.